USANA Health Sciences, Inc. USNA
NYSE
| 10/03/2026 | 07/04/2026 | 04/04/2026 | 01/03/2026 | 09/27/2025 | |
|---|---|---|---|---|---|
| Net Income | -224.77% | -164.96% | -74.57% | -74.40% | -68.74% |
| Total Depreciation and Amortization | 10.23% | 24.03% | 43.29% | 78.60% | 66.38% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 300.93% | 382.19% | 112.23% | 53.71% | -28.02% |
| Change in Net Operating Assets | 51.62% | -174.41% | -330.94% | -231.29% | -293.85% |
| Cash from Operations | 32.13% | -56.00% | -71.72% | -63.36% | -61.19% |
| Capital Expenditure | 5.56% | 1.98% | -41.24% | -37.23% | 17.73% |
| Sale of Property, Plant, and Equipment | -- | 6,404.92% | 6,380.33% | 6,001.56% | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -343.00% | -343.00% | 1,532.08% | -181.18% | -181.18% |
| Cash from Investing | 95.81% | 95.94% | 95.84% | 95.25% | -1,316.61% |
| Total Debt Issued | 1.63% | 1.64% | -6.70% | -25.70% | 1,560.90% |
| Total Debt Repaid | -1.65% | -1.66% | -1,985.89% | -1,713.22% | -1,569.65% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 91.84% | 91.80% | -20.48% | -135.68% | -134.71% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -48.41% | -624.54% | -- | -- | -- |
| Cash from Financing | 86.17% | 82.82% | -523.45% | -525.03% | -144.72% |
| Foreign Exchange rate Adjustments | 251.12% | 114.97% | 417.60% | 182.53% | -177.18% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 115.37% | 109.60% | 88.77% | 84.36% | -479.14% |